Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients

Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients

Background. Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women of reproductive age, whose clinical characteristics are hyperandrogenism (HA), ovulatory dysfunction, and polycystic ovary, often accompanied by insulin resistance (IR) and metabolic abnormalities. Glucagon-li...

Full description

Bibliographic Details
Main Authors:	Jingwen Gan, Jie Chen, Rui-lin Ma, Yan Deng, Xue-song Ding, Shi-yang Zhu, Ai-jun Sun
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2023/4288004

Similar Items

Metagenomics study on taxonomic and functional change of gut microbiota in patients with obesity with PCOS treated with exenatide combination with metformin or metformin alone
by: Jingwen Gan, et al.
Published: (2023-12-01)

The efficacy of metformin and exenatide in Polycystic Ovary Syndrome (PCOS) patients
by: Kesavan, Sanggeeta, et al.
Published: (2023)

Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats
by: Xin Tao, et al.
Published: (2019-09-01)

Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
by: Xuan Du, et al.
Published: (2018-01-01)

Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis
by: Yan Hu, et al.
Published: (2023-11-01)

Triple therapy for obese patients with type 2 diabetes: evaluating effectiveness of the metformin + exenatide + glibenclamide combination
by: M. B. Antsiferov, et al.
Published: (2015-12-01)

The Triad Of PCOS, Infertility And Metformin
by: Ayesha Khan, et al.
Published: (2019-03-01)

The use of metformin in ART for PCOS patients
by: Aboubakr Mohamed Elnashar
Published: (2010-10-01)

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
by: Jia Liu, et al.
Published: (2017-01-01)

C-Reactive Protein in Obese PCOS Women and the Effect of Metformin Therapy
by: Zelija Velija-Ašimi
Published: (2007-02-01)

Efficacy of Metformin in Obese Versus non-Obese Women with Polycystic Ovary Syndrome (PCOS)
by: Fiza Ali Khan, et al.
Published: (2022-11-01)

Clinical observation of laparoscopic sleeve gastrectomy and metformin treatment in obese PCOS patients
by: Ma Qingya, et al.
Published: (2024-01-01)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
by: Jieying Liu, et al.
Published: (2023-07-01)

Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow-up of retrospective cohort
by: Mojca Jensterle, et al.
Published: (2020-01-01)

Efficacy of Metformin-Cabergoline Compared to Metformin Monotherapy for Management of PCOS With Hyperprolactinemia: A Systematic Review and Meta-analysis
by: Aakash Kumar, et al.
Published: (2024-09-01)

The efficacy of metformin and eenatide in polycystic ovary syndrome (PCOS) patients
by: Sanggeeta Kesavan, et al.
Published: (2023-06-01)

HYPOGLYCAEMIC ACTION OF METFORMIN
by: Frayn, K, et al.
Published: (1971)

The hypoglycaemic action of metformin.
by: Frayn, K, et al.
Published: (1971)

Metabolic Action of Metformin
by: Izabela Szymczak-Pajor, et al.
Published: (2022-06-01)

Effect of Metformin Versus Diet and Exercise on Ovulation & Menstrual Regularity in PCOS
by: Nasim Karim, et al.
Published: (2012-01-01)

Curcumin is comparable to metformin for the treatment of PCOS in rats: a preclinical study
by: Salam Shannag, et al.
Published: (2024-02-01)

The effects of metformin on hyperandrogenism and menstrual functions in insulin resistant adolescents with PCOS
by: Recai Pabuçcu, et al.
Published: (2022-05-01)

Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study
by: Selenay Furat Rencber, et al.
Published: (2018-06-01)

The combined effect of metformin and mirabegron on diet‐induced obesity
by: Xin‐Yuan Zhao, et al.
Published: (2023-04-01)

An antiinflammatory actions of exenatide
Published: (2012-12-01)

Long-Term Effectiveness and Cost-Effectiveness of Metformin Combined with Liraglutide or Exenatide for Type 2 Diabetes Mellitus Based on the CORE Diabetes Model Study.
by: Xuesong Zhang, et al.
Published: (2016-01-01)

Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway
by: Shun Zhang, et al.
Published: (2020-06-01)

Treating obesity using the combination of metformin and epigallocatechin-3-gallate
by: Zhican YANG, et al.
Published: (2022-03-01)

Metformin dosage and galectin-3 levels: insights from PCOS patients preparing for IVF
by: Valentina N. Nikolić, et al.
Published: (2025-01-01)

Investigating the synergistic effects of resveratrol and metformin on insulin sensitivity and ovulatory function in women with PCOS
by: Maryam Raana, et al.
Published: (2024-06-01)

Effects of Metformin on CIMT and FMD in PCOS patients: a systematic review and meta-analysis
by: Fang Wang, et al.
Published: (2024-07-01)

Metformin: update on mechanisms of action on liver diseases
by: Gaoyi Ruan, et al.
Published: (2023-12-01)

Myoinositol and Metformin versus Only Metformin in the Management of Gestational Diabetes Mellitus: A Randomised Open-label Clinical Trial
by: Palash Mazumder, et al.
Published: (2023-04-01)

Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin
by: Anbar, H, et al.
Published: (2023)

Exploring the diverse therapeutic benefits of metformin: from anti-cancer to anti-inflammation and PCOS management
by: Nurul Azizah, et al.
Published: (2024-08-01)

Effectiveness of Myoinositol alone or in Companion with Metformin in Improving Hormonal, Metabolic, and Clinical Features of PCOS Women
by: Zainab Abdulhameed Alnisani, et al.
Published: (2023-11-01)

Understanding the action mechanisms of metformin in the gastrointestinal tract
by: Meihui Cheng, et al.
Published: (2024-03-01)

Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial
by: Qing Wen, et al.
Published: (2023-06-01)

Metformin-mediated intestinal AMPK activation ameliorates PCOS through gut microbiota modulation and metabolic pathways
by: Yating Xu, et al.
Published: (2025-02-01)

Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
by: Falbo Angela, et al.
Published: (2010-07-01)